Chromosome 3 imbalances are the most frequent aberration found in non-small cell lung carcinoma

Lung Cancer

Volumn 23, Issue 1, 1999, Pages 61-66

  Lu, Yong Jie ^a,b   Dong, Xiang Yang ^a   Shipley, Janet ^b   Zhang, Ru Gang ^a   Cheng, Shu Jun ^a  

^a CANCER HOSPITAL   (China)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Bronchus; CGH; Chromosome 3; Epithelium; Non small cell lung carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CHROMOSOME 3; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MAPPING; GENOME; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; DNA, NEOPLASM; FEMALE; HUMANS; KARYOTYPING; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0033055594     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(98)00093-2     Document Type: Article

References (27)

1. Minna J.D., Pass H., Glatstein E., Ihde D. Cancer of the lung. DeVita V.T., Hellman S., Sosenberg S.A. Cancer: Principles and Practice of Oncology. 1989;591-705 Lippincott, Philadelphia.
2. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J Clin. 46:1996;5-27.
3. Sobin L.H. The World Health Organization's histological classification of lung tumors: comparison of the first and second editions. Cancer Detect Prev. 5:1982;391-406.
4. Testa J.R., Liu Z.M., Feder M., Bell D.W., Balsara B., Cheng J.Q., Taguchi T. Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet Cytogenet. 95:1997;20-32.
5. Kallioniemi A., Kallioniemi O.-P., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridisation for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
6. Levin N., Brzoska P., Gupta N., Minna J.D., Gray J.W., Christman M.F. Identification of frequent novel genetic alterations in small cell lung carcinoma. Cancer Res. 54:1994;5086-5091.
7. Levin N.A., Brzoska P.M., Warnock M.L., Gray J.W., Christman M.F. Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosomes Cancer. 13:1995;175-185.
8. Petersen I., Langreck H., Wolf G.A.S., Psille R., Vogt P., Reichel M.B., Ried T., Dietel M. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer. 75:1997;79-86.
9. Ried T., Petersen I., Holtgreve-Grez H., Speicher M.R., Schrock E., du Manoir S., Cremer T. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 54:1994;1801-1806.
10. Balsara B.R., Sonoda G., du Manoir S., Siegfried J.M., Gabrielson E., Testa J.R. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res. 57:1997;2116-2120.
11. Bjorkqvist A.-M., Husgafvel-Pursiainen K., Anttila S., Karjalainen A., Tammilheto L., Mattson K., Vainio H., Knuutila S. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer. 22:1998;79-82.
12. Petersen I., Bujard M., Petersen S., Wolf G., Goeze A., Schwendel A., Langreck H., Gellert K., Reichel M., Just K., du Manoir S., Cremer T., Dietel M., Ried T. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res. 57:1997;2331-2335.
13. Lu Y.J., Dong X.Y., Guo S.P., Ke Y., Cheng S.J. Integration of SV40 at 12q23 in SV40-immortalized human bronchial epithelial cells. Carcinogenesis. 17:1996;2089-2091.
14. Lu Y.J., Guo S.P., Tong T., Xu L.H., Dong X.Y., Han N.J., Cheng S.J. Establishment and characterization of an SV40T-transformed human bronchial epithelial cell line. Lung Cancer. 19:1998;15-24.
15. Lu Y.-J., Birdsall S., Osin P., Gusterson B., Shipley J. Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence. Genes Chromosomes Cancer. 20:1997;275-281.
16. Shipley J., Weber-Hall S.J., Birdsall S. Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60 is not associated with a 5q- chromosome; characterization by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer. 15:1996;182-186.
17. Heim S., Mitelman F. Cancer Cytogenetics. Chromosomal and Molecular Genetic Aberrations of Tumor Cells. 2nd ed:1995;369-388 Wiley-Liss, New York.
18. Brass N., Ukena I., Remberger K., Mack U., Subrecht G.W., Meese E.U. DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting. Eur J Cancer. 32A:1996;1205-1208.
19. Smith L., Liu S., Goodrich L., Jacobson D., Degnin C., Bentley N., Carr A., Flaggs G., Keegan K., Hoekstra M., Thayer M. Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest. Nat Genet. 19:1998;39-46.
20. Meisner L.F., Wu S.Q., Christian B.J., Reznikoff C.A. Cytogenetic instability with balanced chromosome changes in an SV40 transformed human uroepithelial cell line. Cancer Res. 48:1988;3215-3220.
21. Rodgers C.S., Hill S.M., Hulten J.A., Chang S.E., Keen J., Taylor-Papadimitriou J. Cytogenetic analysis of SV40-transformed human breast epithelial cells. Cancer Genet Cytogenet. 8:1983;213-221.
22. Roche J., Boldog F., Robinson M., Robinson L., Varella-Garcia M., Swanton M., Waggoner B., Fishel R., Franklin W., Gemmil R., Drabkin H. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene. 12:1996;1289-1297.
23. Sekido Y., Bader S., Latif F., Chen J.-Y., Duh F.-M., Wei M.-H., Albanesi J.P., Lee C.-C., Lerman M.I., Minna J.D. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci USA. 93:1996;4120-4125.
24. Sozzi G., Veronese M.L., Negrini M., Baffa R., Cotticelli M.G., Inoue H., Tornielli S., Pilotti S., De Gregorio L., Pastorino U., Pierotti M.A., Ohta M., Huebner K., Croce C.M. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell. 85:1996;17-26.
25. Sekido Y., Bader S., Latif F., Gnarra J.R., Gazdar A.F., Linehan W.M., Zbar B., Lerman M.I. Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer celll lines. Oncogene. 9:1994;1599-1604.
26. Tanner M.M., Tirkkonen M., Dallioniemi A., Collins C., Stokke T., Karhu R., Kowbel D., Shadravan F., Hintz M., Kuo W.L., Waldman F.M., Isola J.J., Gray G.W. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res. 54:1994;4257-4260.
27. Lu Y.J., Dong X.Y., Guo S., Zhang R.G., Ke Y., Zhang L.Z., Xu L.H., Cheng S.J. 2q-, a non-random chromosomal abnormality in human non-small-cell lung cancer. Carcinogenesis. 17:1996;1589-1593.